J
Jun Ma
Researcher at Harbin Institute of Technology
Publications - 1523
Citations - 58397
Jun Ma is an academic researcher from Harbin Institute of Technology. The author has contributed to research in topics: Nasopharyngeal carcinoma & Medicine. The author has an hindex of 97, co-authored 1338 publications receiving 39643 citations. Previous affiliations of Jun Ma include Shenyang Aerospace University & University of Technology, Sydney.
Papers
More filters
Journal ArticleDOI
Efficient removal of perfluorooctane sulphonate by nanofiltration: Insights into the effect and mechanism of coexisting inorganic ions and humic acid
TL;DR: In this paper, the effect and interaction of anions, cations, and humic acid (HA) on PFOS removal performance and mechanism were examined, and density functional theory (DFT) was applied to calculate the interaction between PFOS molecules, cation, and HA.
Journal ArticleDOI
An integrated model of the gross tumor volume of cervical lymph nodes and pretreatment plasma Epstein–Barr virus DNA predicts survival of nasopharyngeal carcinoma in the intensity-modulated radiotherapy era: a big-data intelligence platform-based analysis:
Jun-Yan Li,Cheng-Long Huang,Wei-Jie Luo,Yuan Zhang,Ling-Long Tang,Hao Peng,Ying Sun,Yu Pei Chen,Jun Ma +8 more
TL;DR: The integrated GTVnd and pre-EBV DNA model not only predicted DMFS and OS in NPC patients effectively, but was an indicator of timely adjustment of therapeutic strategies for NPC patients, especially those completing IC.
Journal ArticleDOI
Famitinib in combination with concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 1, open‐label, dose‐escalation Study
Qiu-Yan Chen,Lin-Quan Tang,Na Liu,Feng Han,Ling Guo,Shan-Shan Guo,Jianwei Wang,Huai Liu,Yanfang Ye,Lu Zhang,Li-Ting Liu,Pan Wang,Ying-Qin Li,Qingmei He,Xiaoqun Yang,Qing-Nan Tang,Yang Li,Yu Jing Liang,Xue Song Sun,Chuanmiao Xie,Yunxian Mo,Ying Guo,Rui Sun,Hao-Yuan Mo,Ka-Jia Cao,Xiang Guo,Mu Sheng Zeng,Hai-Qiang Mai,Jun Ma +28 more
TL;DR: D-CEUS tests showed that more than 60% of patients achieved a perfusion parameter response after 2 weeks taking famitinib alone, and the parameter response was associated with disease improvement, which is a reliable and early measure of efficacy for famit inib therapies.
Journal ArticleDOI
TIPE3 hypermethylation correlates with worse prognosis and promotes tumor progression in nasopharyngeal carcinoma.
Xian Yue Ren,Xin Wen,Ying Qing Li,Jian Zhang,Qing Mei He,Xiao-Jing Yang,Xin-Ran Tang,Ya Qin Wang,Pan Pan Zhang,Xiao Zhong Chen,Bin Cheng,Jun Ma,Na Liu +12 more
TL;DR: TIPE3 downregulation correlates with its CGI hypermethylation in several solid cancers and acts as a tumor suppressor in NPC, providing a further insight into NPC progression and representing a potential prognostic biomarker for NPC.
Journal ArticleDOI
With or without reirradiation in advanced local recurrent nasopharyngeal carcinoma: a case–control study
Li Ting Liu,Qiu Yan Chen,Lin Quan Tang,Lu Zhang,Shan Shan Guo,Ling Guo,Hao Yuan Mo,Chong Zhao,Xiang Guo,Ming Yuan Chen,Chao Nan Qian,Mu Sheng Zeng,Ming Huang Hong,Jian Yong Shao,Ying Sun,Jun Ma,Hai Qiang Mai +16 more
TL;DR: Compared with reiradiation, treating advanced local recurrent NPC with chemotherapy alone warrants further validation in the view of its similar survival and more acceptable toxicities.